Unknown

Dataset Information

0

A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer.


ABSTRACT: BACKGROUND:Our study aimed to determine the effect of probiotic consumption containing six viable microorganisms of 30?×?1010?cfu Lactobacillus and Bifidobacteria strains for six months on clinical outcomes and inflammatory cytokines (TNF-?, IFN-?, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22) in patients with colorectal cancer. METHODS:Fifty-two patients with colorectal cancer were randomized at four weeks after surgery to receive either a placebo (n?=?25) or 30 billion colony-forming unit (CFU) of a mixture of six viable strains including 107?mg of Lactobacillus acidophilus BCMC® 12,130, Lactobacillus lactis BCMC® 12,451, Lactobacillus casei subsp BCMC® 12,313, Bifidobacterium longum BCMC® 02120, Bifidobacterium bifidum BCMC® 02290 and Bifidobacterium infantis BCMC® 02129 (n?=?27). Patients were instructed to take the product orally twice daily for six months. Infection status, diarrhea or hospital admission were recorded throughout the study. Blood was taken pre- and post-intervention to measure TNF-?, IFN-?, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22 using ELISA multiplex kit. RESULTS:The majority of cases (~?70%) were in Duke's C colorectal cancer for both groups. No surgical infection occurred and no antibiotics were required. Chemotherapy induced diarrhea was observed in both groups. Significant reduction in the level of pro-inflammatory cytokine, TNF-?, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22 were observed in CRC patients who received probiotics as compared to pre-treatment level (P?

SUBMITTER: Zaharuddin L 

PROVIDER: S-EPMC6657028 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer.

Zaharuddin Liyana L   Mokhtar Norfilza Mohd NM   Muhammad Nawawi Khairul Najmi KN   Raja Ali Raja Affendi RA  

BMC gastroenterology 20190724 1


<h4>Background</h4>Our study aimed to determine the effect of probiotic consumption containing six viable microorganisms of 30 × 10<sup>10</sup> cfu Lactobacillus and Bifidobacteria strains for six months on clinical outcomes and inflammatory cytokines (TNF-α, IFN-γ, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22) in patients with colorectal cancer.<h4>Methods</h4>Fifty-two patients with colorectal cancer were randomized at four weeks after surgery to receive either a placebo (n = 25) or 30 billio  ...[more]

Similar Datasets

| S-EPMC4603068 | biostudies-literature
2016-07-15 | E-GEOD-76003 | biostudies-arrayexpress
2016-07-15 | GSE76003 | GEO
| S-EPMC4077042 | biostudies-other
| S-EPMC7408996 | biostudies-literature
| S-EPMC8444386 | biostudies-literature
2017-02-09 | GSE74988 | GEO
| S-EPMC5947135 | biostudies-other
| S-EPMC7014653 | biostudies-literature
2024-07-10 | MSV000095296 | MassIVE